George Donato
Chief Operating Officer presso OYSR POIN
Posizioni attive di George Donato
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| OYSR POIN | Chief Operating Officer | - | - |
Storia della carriera di George Donato
Precedenti posizioni note di George Donato
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Iroko Pharmaceuticals, Inc.
 Iroko Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Iroko Pharmaceuticals, Inc. develops and distributes pharmaceutical products. Its products include Indocin and Aldomet. The company was founded on January 18, 2007 and is headquartered in Philadelphia, PA. | Chief Operating Officer | - | - |
Formazione di George Donato
| Widener University | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
Posizioni
| Chief Operating Officer | 2 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Iroko Pharmaceuticals, Inc.
Iroko Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Iroko Pharmaceuticals, Inc. develops and distributes pharmaceutical products. Its products include Indocin and Aldomet. The company was founded on January 18, 2007 and is headquartered in Philadelphia, PA. | Health Technology |
Oyster Point Pharma, Inc.
 Oyster Point Pharma, Inc. Pharmaceuticals: MajorHealth Technology Oyster Point Pharma, Inc. engages in the development and commercialization of pharmaceutical therapies to treat ocular surface diseases. Its product candidate, OC-01, is a nicotinic acetylcholine receptor agonist, which is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. The company was founded by Michael and is Ackermann in June 30, 2015 headquartered in Princeton, NJ. | Health Technology |
- Borsa valori
- Insiders
- George Donato
- Esperienza
